Bioplus History

2019 ~

Entry to total health care and well-being industry from focusing on materials for medical treatment

2021

  • Permission for Graft/Prosthesis, Biomaterial(for export)
  • Graft/Prosthesis,Biomaterial for joint
  • Global Export Power Company Selected
  • Establishing a foothold for Botox business by signing Ora Bio investment and joint management contracts
  • Injection and anti-adhesion drugs approved by the UK Medicines Regulator (MHRA).
  • Establishing a foothold for the biobetter business by signing a contract for ubi protein Co., Ltd. technology cooperation.

2020

  • Approval of GMP and CE at Seongnam Plant 2
  • Entry to the project in hainan island of china as the only domestic company (april 2020)
  • China’s Gangdong New District Signature Ceremony (Dec. 2020)
  • Bio+ Dew™ KFDA Item permission

2019

  •   Mdsapcertification : filler, anti-adhesive barrier agent
  •   Synovial fluid replacement export license (19. 3.)
  •  Synovial fluid replacement irb
  •   Interblock( anti adhesive barrier agent) kfda completion (19. 2.) / ce certification (19. 2.)
  •  Establishment of 5 branches in overseas (dubai, new delhi)
  •   Gyeonggido seongnam 2nd plant and r&d center expansion / business centert gyeonggido seognam (19.10)

2008 ~ 2018

Expansion of R&D intrastructure and construction of cutting-edge manufacturing facilities.

2016 ~ 2018

  •   Global leader in biomaterials
  •   Entry to total health care and well-being industry from focusing on materials for medical treatment
  •   Interblock (anti adhesive barrier agent) irb approved (17. 5.)
  •   Interblock (anti adhesive barrier agent) export license (16. 10.)

2014 ~ 2015

  •   Hyaldew® kfda item PERMISSION
  •   Skinplus-hyal® kfda item PERMISSION
  •   Skinplus-hyal® kgmp(FORMERLY, kfda)
  •   Skinplus-hyal®, deneb® ce CERTIFICATION
  •   Skinplus-hyal® completed clinical trials (seoul national university hospital – seoul, bundang)

2013

  •   Completion OF daejeon plant 1 AND r&d center

2010 ~ 2011

  •   Manufacturing and product license (for export)

2008 ~ 2009

  •   Skinplus-hyal® completed biocompatibility and safety test / completed preclinical test

2003 ~ 2007

Development of products based on polymeric olysaccharide (hyaluronic acid)
Completed various and differentiated world class ha filler lineup

2003

  •    Additional development in applied products based on bio-materials & business expansion
  •  Expansion of r&d intrastructure and construction of cutting-edge manufacturing facilities
  •   Selection of ha based filler and completed development
  •   Performed variety of filler research including collagen and microbead filler
  •   Establishment of bioplus co., ltd.